An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures

Phytomedicine

Volumn 7, Issue 4, 2000, Pages 273-282

  Budzinski, J W ^a   Foster, B C ^b   Vandenhoek, S ^a   Arnason, J T ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

Commercial herbal extracts and tinctures; CYP3A4; Cytochrome P450; Herbal drug interactions; Inhibition; Potential risk

Indexed keywords

CYTOCHROME P450 3A4; DILL APIOLE; HYPERICIN; KETOCONAZOLE; NARINGENIN; PLANT EXTRACT;

ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; DRUG INTERACTION; ENZYME INHIBITION; GLYCYRRHIZA; HYPERICUM PERFORATUM; MATRICARIA; PHYTOCHEMISTRY; PRIORITY JOURNAL;

ANETHUM GRAVEOLENS; ANTHEMIS; CHAMOMILLA; ECHINACEA ANGUSTIFOLIA; FELIS CATUS; GLYCYRRHIZA; GLYCYRRHIZA GLABRA; HYDRASTIS CANADENSIS; HYPERICUM PERFORATUM; MATRICARIA; MATRICARIA CHAMOMILLA; SAINT JOHNS WORT; TRIFOLIUM PRATENSE; UNCARIA TOMENTOSA;

EID: 0033868271     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(00)80044-6     Document Type: Article

References (23)

1. Ameer, B., Weintraub, R. A.: Drug interactions with grapefruit juice. Clin Pharmacokinet. 33: 103-121, 1997.
2. Bailey, D. G., Malcolm, J., Arnold, O., Spence, J. D.: Grapefruit juice-drug interactions. Br J Clin Pharmacol. 46: 101-110, 1998.
3. Bartle, W. R., Ferland, G.: Fiddleheads and the international normalized ratio. N Eng J Med. 338: 1550, 1998.
4. Bergeron, C., Livesey, J., Arnason, J., Awang, D. V. C., Baum, B., Arnason, J. T.: A quantitative HPLC method for Echinacea analysis. Phytochem Anal. 11: 1-9, 2000.
5. Bernard, C. B., Arnason, J. T., Philogene, B. J. R., Lam, J., Waddell, T.: In vivo effect of mixtures of allelochemicals on the life cycle of the European corn borer, Ostrinia nubilalis. Entomol Exp App. 57: 17-22, 1990.
6. Bernard, C. B., Krishnamurty, H. G., Chauret, D., Sanchez, P. E., San Roman, L., Poveda, L. J., Hasbun, C.: Insecticidal Piperaceae of the neotropics. J Chem Ecol. 21: 801-814, 1995.
7. Bernard, C. B., Philogene, B. J. R.: Insecticide synergists: role, importance, and perspectives. J Toxicol Environ Health. 38: 199-223, 1993.
8. Brevoort, P.: The Booming US Botanical Market, Herbal-Gram 44: 33-48, 1998.
9. Chan, W. K., Nguyen, L. T., Miller, V. P., Harris, R. Z.: Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci. 62: 135-142, 1998.
10. Crespi, C. L., Miller, V. P., Penman, B. W.: Microtitre plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem. 248: 188-190, 1997.
11. De Smet, P. A. G. M.: Health risks of herbal remedies. Drug Saf. 13: 81-93, 1995.
12. De Smet, P. A. G. M., Brouwers, J. R. B. J.: Pharmacokinetic evaluation of herbal remedies: basic introduction, applicability, current status and regulatory needs. Clin Pharmacokinet. 32: 427-436, 1997.
13. Foster, B. C., Vandenhoek, S., Hanna, J., Akhtar, M. H., Krantis, A.: Effect of natural health products on cytochrome P-450 drug metabolism. Can J Infections Dis Supp. 10 (B): 18, 1999.
14. Fuhr, U.: Drug interactions with grapefruit juice: extent, probable mechanism, and clinical relevance. Drug Saf. 18: 251-272, 1998.
15. GENTEST: Methodology of a high throughput method for measuring cytochrome P450 inhibition (version 2). Woburn: GENTEST Technical Bulletin, GENTEST Corporation, 1998.
16. Harborne, J. B., Baxter, H., editors: Phytochemical Dictionary: A Handbook of Bioactive Compounds from Plants. London: Taylor & Francis, 1993.
17. He, K., Iyer, K. R., Hayes, R. N., Sinz, M. W., Woolf, T. F., Hollenberg, P. F.: Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol. 11: 252-259, 1998.
18. Kozyrskyj, A.: Herbal products in Canada: how safe are they? Can Fam Physician. 43: 697-702, 1997.
19. Lown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H., Fortlage, L. A., Brown, M. B., Guo, W., Watkins, P. B.: Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest. 10: 2545-2533, 1997.
20. Nebel, A., Schneider, B. J., Baker, R. K., Kroll, D. J.: Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother. 33: 502, 1999.
21. Omar, S.: Isolation of insecticidal and antimalarial bitter principles. PhD Thesis. Ottawa: University of Ottawa, 2000.
22. Taylor, J. R., Wilt, V. M.: Probable antagonism of warfarin by green tea. Ann Pharmacother. 33: 426, 1999.
23. Thummel, K. E., Wilkinson, G. R.: In vitro and in vivo drug interactions involving CYP3A. Annu Rev Pharmacol Toxicol. 38: 389-430, 1998.